HansaBioMed Life Sciences Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 1

HansaBioMed Life Sciences General Information

Description

Manufacturer of biotechnology products intended for extracellular vesicle and exosome research. The company offers isolation kits, purified vesicles, monoclonal antibodies, and specialized laboratory services, designed for academic and industrial researchers to advance scientific discovery in diagnostics and therapeutics.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Mäealuse 2/1
  • Tallinn, 12618
  • Estonia
+372 656
Primary Industry
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Mäealuse 2/1
  • Tallinn, 12618
  • Estonia
+372 656

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HansaBioMed Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HansaBioMed Life Sciences‘s full profile, request access.

Request a free trial

HansaBioMed Life Sciences Patents

HansaBioMed Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015185730-A2 Exosomal biomarkers Inactive 06-Jun-2014
WO-2015185730-A3 Use of tm9sf4 as a biomarker for tumor associated exosomes Inactive 06-Jun-2014
EP-2245465-A1 A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression Active 25-Jan-2008
EP-2245465-B1 A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression Active 25-Jan-2008
WO-2009092385-A1 A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression Inactive 25-Jan-2008 G01N33/5758
To view HansaBioMed Life Sciences’s complete patent history, request access »

HansaBioMed Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HansaBioMed Life Sciences Investments (1)

HansaBioMed Life Sciences’s most recent deal was a Later Stage VC with Exosomics. The deal was made on 17-May-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Exosomics 17-May-2017 Later Stage VC Diagnostic Equipment
To view HansaBioMed Life Sciences’s complete investments history, request access »

HansaBioMed Life Sciences FAQs

  • When was HansaBioMed Life Sciences founded?

    HansaBioMed Life Sciences was founded in 2007.

  • Where is HansaBioMed Life Sciences headquartered?

    HansaBioMed Life Sciences is headquartered in Tallinn, Estonia.

  • What is the size of HansaBioMed Life Sciences?

    HansaBioMed Life Sciences has 13 total employees.

  • What industry is HansaBioMed Life Sciences in?

    HansaBioMed Life Sciences’s primary industry is Biotechnology.

  • Is HansaBioMed Life Sciences a private or public company?

    HansaBioMed Life Sciences is a Private company.

  • What is HansaBioMed Life Sciences’s current revenue?

    The current revenue for HansaBioMed Life Sciences is .

  • When was HansaBioMed Life Sciences acquired?

    HansaBioMed Life Sciences was acquired on 16-May-2017.

  • Who acquired HansaBioMed Life Sciences?

    HansaBioMed Life Sciences was acquired by Lonza Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process